当前位置:首页 - 行情中心 - 百克生物(688276) - 财务分析 - 现金流量表

百克生物

(688276)

  

流通市值:66.19亿  总市值:66.19亿
流通股本:4.14亿   总股本:4.14亿

现金流量表

报告期2026-06-302026-03-312025-12-312025-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金433,640,292.23180,912,146.771,064,804,142.5715,536,143.17
  收到的税费返还--15,100,231.515,100,231.5
  收到其他与经营活动有关的现金29,884,724.6215,641,508.32126,451,051.9566,093,843.22
  经营活动现金流入小计463,525,016.85196,553,655.091,206,355,425.95796,730,217.89
  购买商品、接受劳务支付的现金60,350,138.5633,217,549.3494,507,248.0389,560,071.33
  支付给职工以及为职工支付的现金89,105,135.1151,682,308.93193,744,125.29155,022,986.31
  支付的各项税费9,128,558.866,764,185.3337,088,609.7728,721,431.43
  支付其他与经营活动有关的现金256,583,166.486,204,023.1649,808,384.69538,235,079.42
  经营活动现金流出小计415,166,998.93177,868,066.7975,148,367.78811,539,568.49
  经营活动产生的现金流量净额48,358,017.9218,685,588.39231,207,058.17-14,809,350.6
二、投资活动产生的现金流量:
  处置固定资产、无形资产和其他长期资产收回的现金净额19,30019,30064,400.01-
  投资活动现金流入的平衡项目000-
  投资活动现金流入小计19,30019,30064,400.01-
  购建固定资产、无形资产和其他长期资产支付的现金133,276,150.5176,046,956.07406,486,505.07236,791,093.25
  投资支付的现金35,000,000-50,000,00050,000,000
  投资活动现金流出小计168,276,150.5176,046,956.07456,486,505.07286,791,093.25
  投资活动产生的现金流量净额-168,256,850.51-76,027,656.07-456,422,105.06-286,791,093.25
三、筹资活动产生的现金流量:
  取得借款收到的现金348,386,554.49126,165,360.47334,651,920.07269,084,835.71
  筹资活动现金流入小计348,386,554.49126,165,360.47334,651,920.07269,084,835.71
  偿还债务支付的现金141,190,198.952,948,279.81172,242,939.175,825,726.18
  分配股利、利润或偿付利息支付的现金3,590,202.591,574,249.3875,031,891.8573,346,930.15
  筹资活动现金流出小计144,780,401.4954,522,529.19247,274,830.95149,172,656.33
  筹资活动产生的现金流量净额203,606,15371,642,831.2887,377,089.12119,912,179.38
四、汇率变动对现金及现金等价物的影响-342,390.11-72,815.24-158,504.54-105,967.58
五、现金及现金等价物净增加额83,364,930.314,227,948.36-137,996,462.31-181,794,232.05
  加:期初现金及现金等价物余额201,237,558.03201,237,558.03339,234,020.34339,234,020.34
  期末现金及现金等价物余额284,602,488.33215,465,506.39201,237,558.03157,439,788.29
补充资料:
  净利润-52,100,116.48--262,580,724.19-
  资产减值准备7,394,860.15-71,672,544.95-
  固定资产和投资性房地产折旧49,207,799.48-82,011,531.46-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧49,207,799.48-82,011,531.46-
  无形资产摊销32,679,169.11-48,946,241.22-
  长期待摊费用摊销15,180,418.24-19,134,528.71-
  处置固定资产、无形资产和其他长期资产的损失-18,925.52--63,149.52-
  固定资产报废损失-239,168.52-420,015.39-
  财务费用3,229,410.94-3,780,675.7-
  投资损失-20,634,068.77-34,413,580.92-
  递延所得税-17,499,531.86--65,753,641.7-
  其中:递延所得税资产减少-17,398,972.83--65,653,826.72-
    递延所得税负债增加-100,559.03--99,814.98-
  存货的减少-70,278,511.88--64,506,950.56-
  经营性应收项目的减少85,280,419.99-466,313,947.93-
  经营性应付项目的增加21,826,723--111,408,917.02-
  现金的期末余额284,602,488.33-201,237,558.03-
  减:现金的期初余额201,237,558.03-339,234,020.34-
  现金及现金等价物的净增加额83,364,930.3--137,996,462.31-
公告日期2026-08-212026-04-222026-04-222025-10-31
审计意见(境内)标准无保留意见
TOP↑